Slide 1: 2Q 2024 Investor Presentation
Nasdaq: LNZA 2Q 2024 INVESTOR PRESENTATION August 8, 2024 ©2024 LanzaTech Inc. All rights reserved.
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT These slides and any accompanying oral presentation contain forward-looking statements. All statements, other than statements of historical fact, included in these slides and any accompanying oral presentation are forward-looking statements reflecting management’s current belie
Slide 3: Financial Information & Non-GAAP Financial Measures
FINANCIAL INFORMATION & NON-GAAP FINANCIAL MEASURES To supplement our financial statements presented in accordance with US GAAP and to provide investors with additional information regarding our financial results, we have presented adjusted EBITDA, a non- GAAP financial measure. Adjusted EBITDA is n
Slide 4: 2Q 2024 Highlights
2Q 2024 HIGHLIGHTS 1 | Delivered solid financial 2 |Executed on all key results, ahead of aspects of business expectations ▪ Solid progress achieved in ▪ Revenue: $17.4M Biorefining, Joint Development & ▪ Gross margin: 68% Contract Research, and ▪ Gross profit: $11.9M CarbonSmart 3 | Increased shar
Slide 5: Overview of 2Q 2024 Financial Results
OVERVIEW OF 2Q 2024 FINANCIAL RESULTS SUMMARY FINANCIAL RESULTS¹ COMMENTARY Revenue: ▪ Revenue increased 35% YoY in 2Q24, exceeding LanzaTech’s expectations ▪ Growth driven by ~$7.9M of biorefining licensing revenue associated with license of LanzaTech’s technology to LanzaJet and the further sublic
Slide 6: 2024 Full-Year Guidance Reaffirmed
2024 FULL-YEAR GUIDANCE REAFFIRMED REVENUE GUIDANCE: $90M - $105M ADJUSTED EBITDA1 GUIDANCE: $(65)M - $(55)M Drivers of 2H24 Step Up: $90 2024 Revenue Projection ▪ Several projects expected to progress ($M) to FID stage of development during $80 2H24 driving: $70 Guidance Range $15 MM → Increase in
Slide 7: Strong Pipeline That Positions the Company for Continued Growth and Scale
STRONG PIPELINE THAT POSITIONS THE COMPANY FOR CONTINUED GROWTH AND SCALE ACTIVE BIOREFINING CUSTOMER PROJECT PIPELINE1 KEY PIPELINE CHARACTERISTICS1 70+ 1 net addition into this stage Active Engagements with Positive Technoeconomic Results ~83,000 tons Avg. Plant Capacity 30+ 5 net additions into t
Slide 8: Additional Financial Information
Nasdaq: LNZA ADDITIONAL FINANCIAL INFORMATION August 8, 2024
Slide 9: Result of Operations – Three Months Ended June 30, 2024
RESULT OF OPERATIONS – THREE MONTHS ENDED JUNE 30, 2024 Three Months Ended June 30, Change 2024 2023 2024 vs. 2023 (In thousands, except for per share amounts) Total revenue $ 17,375 $ 12,917 $ 4,458 35 % Cost of revenue (exclusive of depreciation shown below) (5,491) (10,827) 5,336 (49) % Operating
Slide 10: Reconciliation of Net Loss to Adjusted EBITDA
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA Three Months Ended June 30, Six Months Ended June 30, (In thousands) 2024 2023 2024 2023 Net Loss $ (27,799) $ (26,786) $ (53,307) $ (90,098) Depreciation 1,458 1,348 2,988 2,605 Interest income, net (513) (1,701) (1,661) (1,915) Income tax expense — — —